Drugs used for the treatment of autoimmune disease Flashcards

(29 cards)

1
Q

Non-steroidal anti-inflammatory drugs

A

Cyclooxygenase inhibitors
leads to inhibition of prostaglandin synthesis

  • anti-inflammatory effects
  • analgesic effects (reduction in pain)
  • antipyretic effects (reduction of body temperature)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Effects of prostaglandins

A
  • powerful vasodilation
  • decrease in blood flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cyclooxygenase

A

Two isoforms:
COX-1
COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COX-1

A

expressed in most tissues

house keeping role involved in tissue homeostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

COX-2

A

expression induced in activated inflammatory cells

expression induced by cytokines IL-1 and TNF-alpha (pro-inflammatory signals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anti-inflammatory action of NSAIDs is due to

A

inhibition of COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-selective NSAIDs

A

Aspirin
Ibuprofen
Paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COX-2 inhibitors

A

NO DIRECT EFFECT on immune processes that contribute towards tissue damage (ie accumulation of inflammatory cells is not reduced) → do not inhibit T cell activation, release of cytokines or ROS, they relieve symptoms of autoimmune disease so the disease will still progress

Reduce vasodilation, oedema and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COX enzyme

A

long channel and circular catalytic centre

arachidonic acid travels down channel, enters active site and binds to enzyme

catalyses conversion of arachidonic acid to prostaglandin E2

prostaglandin E2 has a lower affinity for the enzyme, travels back down channel and released into body cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-selective NSAIDs - mechanism

A

NSAIDs interact with binding site in channel of cyclooxygenase - found in both COX-1 and 2

binding blocks substrate from travelling down channel

prevents substrate activating enzyme

stops production of mediator of prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism of COX-2 selectivity

A

COX-2 has wider channel and additional binding site for drugs

  • made drug bigger so it no longer fit in COX-1 channel → induced COX-2 selectivity
  • created drugs with side chain that interacts with second binding site in COX-2 → increased potency of drug as drug now has two binding sites to react with
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common adverse effects of NSAIDs

A
  • Gastric irritation
  • Effect on renal blood flow
  • A tendency to prolong bleeding through inhibiting platelet function
  • Increased likelihood of thrombotic events including myocardial infarction (especially COX-2 selective drugs – through inhibiting
    prostaglandin I2) → several of the drugs were removed from market due to this reason
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Immunosuppressant drugs

A

Interact directly with immune system, blocking activation and proliferation of T-cells and release of mediators from macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cyclosporin

A

Inhibits IL-2 production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Corcitosteroids

A

inhibit cytokine gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Azathioprine

A

inhibit purine or pyrimidine synthesis, interfering with DNA replication

17
Q

Cyclosporin mechanism of action

A

Deceased proliferation of T-cells by inhibiting IL-2 release
Reduces function of effector T-cells that secrete cytokines, which mediate autoimmune reactions

Cyclosporin binds to a cytosolic protein in T-cells called CYCLOPHILIN

Inhibits transcription factor activation and synthesis of IL-2

18
Q

Glucocorticoids

A

Adrenal steroids – endogenous substances that maintain a low level of anti-inflammatory action

Main drugs include: hydrocortisone, prednisolone and dexamethasone

Powerful anti-inflammatory and immunosuppressive agents
Through the suppression of many genes → suppressing gene transcription and protein synthesis

19
Q

Actions of glucocorticoids on inflammatory cells

A

Reduced activity of macrophages by decreasing gene transcription
of cytokines (Il-2, TNFalpha, IFN-gamma)

Deceased action of helper T-cell by decreased proliferation → need protein synthesis, stops T cells dividing

Decreased production of cytokines involved in inflammation

Decreased production of nitric oxide, histamine and prostanoids → these mediators are synthesised by enzymes, glucocorticoids block production of the enzymes and hence block production of mediators

OVERALL, this leads to a reduction in chronic inflammation and
Autoimmune reactions

20
Q

Glucocorticoids - mechanism of action

A

Bind intracellular cytoplasmic glucocorticoid receptors that then dimerize

Activates receptor to undergo conformational change

Exposes DNA binding domain

Steroid-receptor complex translocates to nucleus

Interacts with glucocorticoid response elements, Fos/Jun or NFkappaB to modify gene transcription

21
Q

Azathioprine

A

Interferes with purine synthesis and is cytotoxic

Widely used for immunosuppression for control of tissue rejection in transplant surgery

Azothioprine (pro-drug) is metabolised: → mercaptopurine

Mercaptopurine - Purine analogue that inhibits DNA synthesis → interferes with natural DNA synthesis

SINCE, DNA synthesis is required for T-cell proliferation, azothioprine can also be used to inhibit cell-mediated immune reactions

22
Q

Antirheumatoid drugs

A

Immunosuppressants
Glucocorticoids
NSAIDS – reduce symptoms but do not retard the progress of the disease
Disease modifying anti-rheumatoid drugs

23
Q

Effects of disease-modifying anti-rheumatoid drugs

A
  • Improve symptoms and reduce disease activity
  • swollen and tender joints
  • pain
  • disability

Often used as second line treatment since they are slow in onset - sometimes takes months before seeing clinical benefit

Initially taken alongside immunosuppressants and NSAIDs

24
Q

Sulfasalazine

A

Produces remission in rheumatoid arthritis

Thought to work via reducing activity of phagocytes (macrophages / neutrophils) by scavenging ROS and / or nitric oxide → exact mechanism not fully defined

-reducing amount of mediators circulating around joints is beneficial for autoimmune disease

25
Gold compounds
effect develops slowly (3-4 months) Pain and joint swelling subsides Mechanism of action not known – may inhibit cytokine secretion from phagocytes
26
Anti-cytokine therapy
Target one specific cytokine so target one specific autoimmune disease pathway without affecting the rest of the immune system Treatment aimed at specific-aspects of the immune response Drugs are “biopharmaceuticals” → monoclonal antibodies *Recombinant engineered antibodies specific for human protein* *THUS – difficult to produce and expensive* *They are administered in the UK to patients resistant to other DMARDs*
27
Infliximab
Monoclonal antibody against TNF-alpha Binds to TNF-alpha and prevents its action - won’t bind to its receptor
28
Basiliximab
Monoclonal antibody against IL-2 receptor Binds to IL-2 receptor and prevents effective T-cell proliferation **Since it is a protein, it must be given by injection – every 2-8 weeks** - can't be given orally as they will be broken down
29
Anakinara
IL-1beta receptor antagonist